Radiotherapy and gemcitabine-docetaxel chemotherapy in children and adolescents with unresectable recurrent or refractory osteosarcoma.

@article{Lee2016RadiotherapyAG,
  title={Radiotherapy and gemcitabine-docetaxel chemotherapy in children and adolescents with unresectable recurrent or refractory osteosarcoma.},
  author={Jun Ah Lee and Eun Kyung Paik and Juhee Seo and Dong Ho Kim and Jung Sub Lim and Ji young Yoo and Mi-sook Kim},
  journal={Japanese journal of clinical oncology},
  year={2016},
  volume={46 2},
  pages={138-43}
}
OBJECTIVE Few reports have described the treatment outcome of osteosarcoma using radiotherapy. We evaluated the efficacy of radiotherapy and gemcitabine and docetaxel chemotherapy for patients with unresectable recurrent or refractory osteosarcoma. METHODS Data from six patients (five male, one female) who received radiotherapy and gemcitabine and docetaxel chemotherapy at the Korea Cancer Center Hospital were retrospectively reviewed. Tumor response was evaluated according to metabolic… CONTINUE READING